Hydrochloric acid is conventionally used to pre-hydrolyse starch before periodate oxidation into dialdehyde starch (DAS), which may generate chloride-containing waste. This study proposes a sustainable one-step hydrolysis–oxidation route using acetic acid, a biodegradable organic acid, evaluating reaction time (24–72 h) to maximise aldehyde content while minimising acid hazard. Acetic-acid-derived DAS (24 h) achieved a significantly higher aldehyde content than the HCl route (59.57 ± 0.55% vs. 49.91 ± 1.00%; p < 0.001). This DAS was applied as a covalent crosslinker in chitosan/poly(vinyl alcohol) films loaded with Artemisia herba-alba extract, benchmarked against a non-crosslinked film. Crosslinking increased tensile strength (67.1 vs. 51.5 MPa) and crystallinity (40.83% vs. 17.04%), reduced porosity, and slowed extract release in phosphate-buffered saline (27.5% vs. 41.9% at 168 h; Weibull model, Adj. R2 ≥ 0.97) while preserving predominantly Fickian diffusion. Despite releasing less extract, the crosslinked film retained significantly higher DPPH radical-scavenging activity, consistent with hemiacetal interactions between residual aldehydes and extract phenolics. Antibacterial testing against six clinical strains suggested that crosslinking modulates rather than suppresses activity. These findings support acetic-acid-mediated DAS synthesis as a low-hazard, waste-reducing route toward bioactive, controlled-release biopolymer films as promising candidates for future biomedical or active-packaging applications.
We report on the elaboration of a biocompatible therapeutic model system (TMS) capable of detecting the state of chronicity of a wound and responding to the latter by releasing the appropriate healing agent (antibiotic but not only). Different formulations of PVA-borate hydrogel systems containing methylene blue (MB) and levofloxacin (L) drug antibiotic were prepared. We were able to demonstrate sensitivity to microenvironmental factors such as pH, and high levels of ROS – a major biomarker of a chronic inflammation state. Furthermore, these reversible gels “open” and enact an ROS triggered drug delivery response. These results are promising in that they provide a potent wound dressing layer capable of sensing the chronic state of a wound and responding conditionally to the latter by delivering the appropriate amount of drug only when required. Furthermore, our system may be optimized for chronic wound dressing healing and promote better wound care by limiting unnecessary overexposure of the patient to the antibiotic. Our system provides a potent novel tool to the arsenal of existing strategies aiming at combatting bacterial resistance to antibiotics – a global societal challenge. Our results additionally confirmed good biocompatibility for skin tissue regeneration.
22 May 2026 in Journal of Materials Science: Materials in Medicine
Chronic wounds constitute a significant medical, societal, and economic issue due to the significant delay in wound closure, leading to the increased risk of infection, which extends patients’ time spent in the hospital and negatively impacts overall health. Biofunctional biomaterials have emerged as powerful tools to promote tissue regeneration by mimicking extracellular matrix properties and delivering therapeutic agents. Furthermore, wound closure is a complex and multi-stage process that requires coordination of molecular and cellular factors, such as growth factor signaling and matrix remodeling agents. To address this issue, hierarchically structured and compartmentalized multifunctional biomaterials that include hydrogels have emerged as an effective solution to promote wound healing. In the context of chronic wounds, Reactive Oxygen Species (ROS)-responsive hydrogels are interesting models which specifically trigger a response (e.g., gel opening followed by drug release) in the vicinity of high levels of ROS – specific biomarkers of a chronic state. In this study, we developed a hierarchical multi-layer hybrid biomaterial (HMHB) via the sequential combination of melt electrowriting (MEW) and electrospinning techniques. This HMHB will contain two parts: (i) a macro/micro structured polycaprolactone (PCL) support (MSS) printed via MEW onto which (ii) a polyvinyl alcohol (PVA) electrospun (micro)fibrous film (EFF) was deposited, resulting in a ROS-responsive bioactive antibacterial hydrogel meshwork upper layer that allows for further biofunctionalization. The final construct exhibited a hierarchical architecture composed of a mechanically robust PCL framework and a PVA nanotextured layer. This configuration ensured both structural integrity and homogeneous fiber coverage. Incorporation of Nisin (an antibacterial agent) directly into the EFF prior to the electrospinning step conferred effective antimicrobial activity against Staphylococcus epidermidis, without the need for additional chemical modification. These results establish the HMHB as a promising proof-of-concept for modular and multifunctional wound dressing elaboration. Graphical Abstract The alternative text for this image may have been generated using AI.